Drug tolerance per sisters (DTPs) were formed in EGFR mutant lung cancer cell lines were treated with gefitinib and characterized by increased senescence (CD133 low) and stemness (marked by CD133 high population). This evidence concerns the gene PROM1 and lung cancer.